drugset / Trial / NCT00028327

Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care

NCT00028327 ↗

RandomizedFactorialOpen-labelTreatment

Summary

Many HIV infected patients admitted to the intensive care area (ICA) have never taken anti-HIV drugs. The purpose of this study is to learn whether starting anti-HIV drugs while patients are in an ICA will help them to survive and get better faster. This study will also evaluate patients who, though not in an ICA, have been admitted to the hospital for serious illnesses or infections.

Timeline

Start
—
Primary completion
2004-07
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Efavirenz Other / unclassified — —
Subject Lamivudine Other / unclassified — —
Subject Nelfinavir Other / unclassified — —
Subject Zidovudine Small molecule — —